• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity.回应：非重症COVID-19中的皮质类固醇：寻找机会窗口
Indian J Crit Care Med. 2022 Mar;26(3):405. doi: 10.5005/jp-journals-10071-24139.
2
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19.关于在非重症新型冠状病毒肺炎中使用皮质类固醇的专家共识声明
Indian J Crit Care Med. 2021 Nov;25(11):1280-1285. doi: 10.5005/jp-journals-10071-23923.
3
Corticosteroids for Non-severe COVID-19: Primum Non Nocere.用于非重症新型冠状病毒肺炎的皮质类固醇：首要的是勿伤。
Indian J Crit Care Med. 2022 Mar;26(3):403-404. doi: 10.5005/jp-journals-10071-24138.
4
Tocilizumab and COVID-19.托珠单抗与新型冠状病毒肺炎
Indian J Crit Care Med. 2020 Sep;24(9):741-743. doi: 10.5005/jp-journals-10071-23608.
5
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.基于 COVID-19、其他冠状病毒感染、流感、社区获得性肺炎和急性呼吸窘迫综合征的证据评估 COVID-19 中皮质类固醇的疗效和安全性：系统评价和荟萃分析。
CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14.
6
Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome.重症新型冠状病毒肺炎相关急性呼吸窘迫综合征患者有创机械通气时机与死亡率
Indian J Crit Care Med. 2021 May;25(5):493-498. doi: 10.5005/jp-journals-10071-23816.
7
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.新型冠状病毒肺炎（COVID-19）中的细胞因子风暴：专家管理考量
Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.
8
COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation.新型冠状病毒肺炎相关肺隐球菌病：1例罕见病例报告
Indian J Crit Care Med. 2022 Jan;26(1):129-132. doi: 10.5005/jp-journals-10071-24084.
9
Pediatric Acute Respiratory Distress Syndrome in COVID-19 Pandemic: Is it the Puzzle of the Century?新冠疫情中的儿童急性呼吸窘迫综合征：这是世纪难题吗？
Indian J Crit Care Med. 2022 Mar;26(3):264-265. doi: 10.5005/jp-journals-10071-24175.
10
Airway Management and Related Procedures in Critically Ill COVID-19 Patients: Position Statement of the Indian Society of Critical Care Medicine.危重症COVID-19患者的气道管理及相关操作：印度重症医学学会立场声明
Indian J Crit Care Med. 2020 Aug;24(8):630-642. doi: 10.5005/jp-journals-10071-23471.

本文引用的文献

1
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.COVID-19 相关的鼻眶脑毛霉菌病：系统评价、荟萃分析和荟萃回归分析。
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
2
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19.关于在非重症新型冠状病毒肺炎中使用皮质类固醇的专家共识声明
Indian J Crit Care Med. 2021 Nov;25(11):1280-1285. doi: 10.5005/jp-journals-10071-23923.
3
Delphi methodology in healthcare research: How to decide its appropriateness.医疗保健研究中的德尔菲法：如何确定其适用性。
World J Methodol. 2021 Jul 20;11(4):116-129. doi: 10.5662/wjm.v11.i4.116.
4
Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis.胸部高分辨率计算机断层扫描在2019冠状病毒病患者诊断和评估中的作用——一项系统评价和荟萃分析。
Eur J Radiol Open. 2021;8:100350. doi: 10.1016/j.ejro.2021.100350. Epub 2021 May 13.
5
Immune determinants of COVID-19 disease presentation and severity.COVID-19 疾病表现和严重程度的免疫决定因素。
Nat Med. 2021 Jan;27(1):28-33. doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.
6
A living WHO guideline on drugs for covid-19.关于新冠病毒药物的世界卫生组织实用指南。
BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.Meta 分析研究严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）肺炎的临床特征、结局和严重程度之间的关系。
Am J Infect Control. 2021 Jan;49(1):82-89. doi: 10.1016/j.ajic.2020.06.008. Epub 2020 Jun 12.

回应：非重症COVID-19中的皮质类固醇：寻找机会窗口

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity.

作者信息

Nasa Prashant, Chaudhry Dhruva

机构信息

Department of Critical Care Medicine, NMC Specialty Hospital, Dubai, United Arab Emirates.

Department of Pulmonary and Critical Care, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.

出版信息

Indian J Crit Care Med. 2022 Mar;26(3):405. doi: 10.5005/jp-journals-10071-24139.

DOI:10.5005/jp-journals-10071-24139
PMID:35519915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9015913/
Abstract

Nasa P, Chaudhry D. In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity. Indian J Crit Care 2022;26(3):405.

摘要

纳萨 P、乔杜里 D。回应：非重症 COVID-19 中的皮质类固醇：寻找机会窗口。《印度重症监护杂志》2022 年；26(3):405。